UTX coordinates TCF1 and STAT3 to control progenitor CD8+ T cell fate in autoimmune diabetes

By afschroeder • December 17, 2025

Chen HC, Bang MF, Wang HH, Shpargel KB, Kohn LA, Sailer D, Zhang S, McCarthy EC, Seyedsadr M, Stevens S, Pham CLH, Zhou Z, Yin X, Wilkinson NM, Peluso EM, Bustillos C, Ortega JG, Yang L, Buzzelli AA, Capati RC, Chia DJ, Mittelman SD, Reh CM, Whitmire JK, Lechner MG, Hugo W, Su MA. UTX coordinates TCF1 and STAT3 to control progenitor CD8+ T cell fate in autoimmune diabetes. J Clin Invest. 2025 Dec 16:e196325. doi: 10.1172/JCI196325. Epub ahead of print. PMID: 41401033.

Tags: Allergy & Immunology, Autoimmune Diseases, autoimmunity, Dermatology, diabetes, Endocrinology, epigenetics, Immunology, Publications

FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma

Corren J, Reid F, Moate R, Jimenez E, Sadiq MW, Williams A, Rytelewski M, Cameron-Christie S, Muthas D, Georgi B, Brooks D, Lindqvist E, Kell[...]

Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkers

Riemann S, Meulmeester FL, Mailhot-Larouche S, Ramakrishnan S, Wechsler ME, Corren J, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Laugerud[...]

The Possible Unveiling of Myasthenia Gravis via Allergy Shots

Thakor Philipp A, Anderson L. The Possible Unveiling of Myasthenia Gravis via Allergy Shots. Cureus. 2025 Sep 9;17(9):e91927. doi: 10.7759/cureus.91927. PMID: 41080268; PMCID: PMC12510673.